7.8-Dihydroxycoumarin exerts antitumor potential on DMBA-induced mammary carcinogenesis by inhibiting ERalfa, PR, EGFR, and IGF1R: involvement of MAPK1/2-JNK1/2-Akt pathway
Kumar, Abhishek; Sunita, Priyashree; Jha, Shivesh; Pattanayak, Shakti P.
Artículo
en Inglés
| IBECS (España) | ID: ibc-178979